534 Views | 617 Downloads
Correspondence to Dr Stéphane Joost; stephane.joost@epfl.ch
SJ, SD and IG designed the research; SJ, SD and IG analysed the data and wrote part of the paper; SJ and IG wrote the paper.
SJ, IG, PM-V, GW and PV collected the data.
SJ, SD, IG and J-MT were responsible for the preparation of data.
All the authors undertook revisions, contributed intellectually to the development of this paper and approved the final manuscript. IG is the guarantor.
The authors are grateful to the participants of the CoLaus study and to the investigators, in particular Prof Martin Preisig.
Competing interests: GW reports unrestricted grant from GlaxoSmithKline, and grants from Swiss national Science Foundation, during the conduct of the study.
The CoLaus study was supported by research grants from GlaxoSmithKline, the Faculty of Biology and Medicine of Lausanne, Switzerland, and the Swiss National Science Foundation (grants 33CSCO-122661, 33CS30-139468 and 33CS30-148401).
SS is supported by an Ambizione Grant (n PZ00P3_147998) from the Swiss National Science Foundation.
© 2016, British Medical Journal Publishing Group